Letter to the editor: Evidence on the use of l-ornithine l-aspartate in overt HE-But does it really improve prognosis?
- PMID: 34957567
- DOI: 10.1002/hep.32309
Letter to the editor: Evidence on the use of l-ornithine l-aspartate in overt HE-But does it really improve prognosis?
Comment in
-
Reply.Hepatology. 2022 Apr;75(4):1066-1067. doi: 10.1002/hep.32305. Epub 2022 Jan 12. Hepatology. 2022. PMID: 34951718 No abstract available.
Comment on
-
L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.Hepatology. 2022 May;75(5):1194-1203. doi: 10.1002/hep.32255. Epub 2021 Dec 21. Hepatology. 2022. PMID: 34822189 Clinical Trial.
References
-
- Jain A, Sharma BC, Mahajan B, Srivastava S, Kumar A, Sachdeva S, et al. l ‐Ornithine l ‐aspartate in acute treatment of severe hepatic encephalopathy: a double‐blind randomized controlled trial. Hepatology. 2021. https://doi.org/10.1002/hep.32255 - DOI
-
- Sidhu SS, Sharma BC, Goyal O, Kishore H, Kaur N. l ‐Ornithine l ‐aspartate in bouts of overt hepatic encephalopathy. Hepatology. 2018;67(2):700–10.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources